Workflow
Live)
icon
Search documents
Eni's Renewable Arm Plenitude Attracts Investment Interest From Ares
ZACKS· 2025-05-16 18:21
Group 1 - Eni S.p.A is exploring the sale of a 20% stake in its renewable and retail business Plenitude, engaging in exclusive discussions with Ares Alternative Credit Management [1][2] - The equity value of Plenitude is estimated between 9.8 billion and 10.2 billion euros, with potential to exceed 12 billion euros when considering debt [2] - The sale aligns with Eni's satellite strategy, aimed at developing low-carbon businesses and attracting external investments [3][5] Group 2 - Eni's strategy includes selling small stakes in its business units to support capital expenditures for low-carbon initiatives while retaining investment capacity in upstream projects [3][4] - The interest from Ares highlights the attractiveness of Eni's business model and its growth prospects [4] - Eni has previously executed similar transactions, including a stake sale in Plenitude to Energy Infrastructure Partners and a 30% interest in its biofuel unit Enilive to KKR [5]
Emergent BioSolutions(EBS) - 2025 Q1 - Earnings Call Presentation
2025-05-07 21:04
Q1 2025 Financial Results May 7, 2025 1 Safe Harbor Statement/Trademarks There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including, among others, the availability of USG funding for contracts related to procurement of our medical countermeasure ("MCM") products, including CYFENDUS® (Anthrax Vaccine Adsorbed (AVA) Adjuvanted), previously known as AV7909, and ACAM2000® (Smallpox (Vaccinia) Vaccine, Live), ...